Ligand validation:6H4Q

FO2: 8-[4-(1-methylpiperidin-4-yl)pyrazol-1-yl]-3~{H}-pyrido[3,4-d]pyrimidin-4-one

FO2 is a Ligand Of Interest in 6H4Q designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6H4Q_FO2_B_403	72%	56%	0.143	0.967	0.82	0.87	1	1	0	0	100%	0.83
6H4Q_FO2_D_403	72%	55%	0.145	0.969	0.84	0.9	1	2	0	0	100%	0.74
6H4Q_FO2_A_403	61%	57%	0.169	0.959	0.79	0.86	1	1	0	0	100%	0.74
6H4Q_FO2_C_403	57%	58%	0.174	0.949	0.74	0.88	-	2	0	0	100%	0.79
6H4U_FO2_C_403	60%	61%	0.148	0.94	0.67	0.81	1	1	0	0	96%	0.7174
6H50_FO2_A_809	11%	56%	0.364	0.892	0.88	0.82	1	1	0	0	96%	0.6696

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.